MICOT
LIVE

Serial Number

79356741

Owner

Shaanxi Micot Pharmaceutical Technology

Attorney

Eric Lamb

Filing Date

Sep 30, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MICOT Trademark

Serial Number: 79356741 • Registration: 7369590

MICOT is a trademark filed by Shaanxi Micot Pharmaceutical Technology on September 30, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Shaanxi Micot Pharmaceutical Technology

Room B06, 26th Floor, Building 5,

Entity Type: 03

Shaanxi Micot Technology Co., Ltd.

Room B06, 26th Floor, Building 5,

Entity Type: 03

Trademark Details

Filing Date

September 30, 2022

Registration Date

April 30, 2024

Published for Opposition

February 13, 2024

Goods & Services

Capsules for medicines; medicines for human purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; injectable solutions for medical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; biochemical medicines, namely, prescription pills, tablets, capsules, caplets and pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; drugs for medical purposes, namely, pharmaceutical drug preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; pre-filled syringes for medical purposes; chemical preparations for pharmaceutical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; chemico-pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; vaccines; dietetic substances adapted for medical use; feed additives for veterinary preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; Medicated animal washes; preparations for destroying noxious animals

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
May 29, 2025 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 17, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 28, 2024 FICS
FINAL DISPOSITION PROCESSED
Oct 28, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Feb 14, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 24, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 9, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 9, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 9, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 9, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 18, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 18, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 18, 2023 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 16, 2023 ADCH
REFUSAL PROCESSED BY IB
Sep 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 18, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 22, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 21, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 17, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 7, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 1, 2022 REPR